Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 23507424)

1.

Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.

Barbosa SP, Lins LC, Fonseca FA, Matos LN, Aguirre AC, Bianco HT, Amaral JB, França CN, Santana JM, Izar MC.

Life Sci. 2013 May 2;92(14-16):845-51. doi: 10.1016/j.lfs.2013.02.018. Epub 2013 Mar 16.

2.

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.

Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP.

Curr Med Res Opin. 2008 Jan;24(1):249-59.

PMID:
18053317
3.

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.

Kasmas SH, Izar MC, França CN, Ramos SC, Moreira FT, Helfenstein T, Moreno RA, Borges NC, Figueiredo-Neto AM, Fonseca FA.

Braz J Med Biol Res. 2012 Nov;45(11):1095-101. Epub 2012 Jul 19.

4.

Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.

Okada K, Kimura K, Iwahashi N, Endo T, Himeno H, Fukui K, Kobayashi S, Shimizu M, Iwasawa Y, Morita Y, Wada A, Shigemasa T, Mochida Y, Shimizu T, Sawada R, Uchino K, Umemura S.

Circ J. 2011;75(10):2496-504. Epub 2011 Aug 2.

5.

Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.

Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D.

Am J Cardiol. 2007 Jun 15;99(12):1706-1713. Epub 2007 May 2.

PMID:
17560879
6.

Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients.

Thongtang N, Lin J, Schaefer EJ, Lowe RS, Tomassini JE, Shah AK, Tershakovec AM.

Atherosclerosis. 2012 Dec;225(2):388-96. doi: 10.1016/j.atherosclerosis.2012.09.001. Epub 2012 Sep 13.

7.

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

Jakulj L, Vissers MN, Groen AK, Hutten BA, Lutjohann D, Veltri EP, Kastelein JJ.

J Lipid Res. 2010 Apr;51(4):755-62. doi: 10.1194/jlr.M001487. Epub 2009 Oct 14.

8.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
9.

Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study.

Derdemezis C, Filippatos T, Tselepis A, Mikhailidis D, Elisaf M.

Expert Opin Pharmacother. 2008 Aug;9(11):1829-37. doi: 10.1517/14656566.9.11.1829 .

PMID:
18627322
10.
11.

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group.

Am Heart J. 2004 Sep;148(3):447-55.

PMID:
15389231
12.

Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.

Qi Y, Liu J, Ma C, Wang W, Liu X, Wang M, Lv Q, Sun J, Liu J, Li Y, Zhao D.

J Lipid Res. 2013 Nov;54(11):3189-97. doi: 10.1194/jlr.P040360. Epub 2013 Aug 20.

13.

Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.

Niesor EJ, Chaput E, Staempfli A, Blum D, Derks M, Kallend D.

Atherosclerosis. 2011 Dec;219(2):761-7. doi: 10.1016/j.atherosclerosis.2011.09.017. Epub 2011 Sep 16.

PMID:
21982411
14.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
15.

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.

Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP; Ezetimibe Study Group.

Circulation. 2003 May 20;107(19):2409-15. Epub 2003 Apr 28.

16.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

PMID:
20487050
17.

Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.

Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, Bianco HT, do Amaral JB, Izar MC.

Cell Biochem Biophys. 2014 Sep;70(1):687-96. doi: 10.1007/s12013-014-9973-9.

PMID:
24777811
18.

[Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].

Márk L, Paragh G.

Orv Hetil. 2007 Apr 8;148(14):627-32. Review. Hungarian.

PMID:
17403635
19.

C-reactive protein levels and outcomes after statin therapy.

Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.

N Engl J Med. 2005 Jan 6;352(1):20-8.

20.

Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.

Azar RR, Badaoui G, Sarkis A, Azar M, Aydanian H, Harb S, Achkouty G, Kassab R.

Am J Cardiol. 2010 Jul 15;106(2):193-7. doi: 10.1016/j.amjcard.2010.03.016.

PMID:
20599002
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk